Predictors of persistent disease following initial thyroid cancer management

Area of Science:

• Endocrinology
• Oncology
• Surgical Oncology

Background:

• Thyroid carcinoma, encompassing differentiated and poorly differentiated types, presents a significant oncological challenge.
• Identifying prognostic factors for persistent disease is crucial for optimizing patient management and outcomes.

Purpose of the Study:

• To investigate factors associated with persistent differentiated and poorly differentiated thyroid carcinoma.
• To identify predictors of treatment response in thyroid cancer patients.

Main Methods:

• Retrospective chart review of 186 differentiated and poorly differentiated thyroid cancer patients (2004-2018).
• Logistic regression analysis to determine factors associated with less than excellent treatment response.

Main Results:

• 55.9% of patients achieved an excellent treatment response within the first year.
• Lymph node metastasis, extrathyroidal extension, vascular invasion, and multifocality were inversely associated with excellent response.
• Multivariate analysis identified lymph node metastasis as a significant predictor of decreased odds of an excellent response (p=0.007).

Conclusions:

• Lymph node metastasis is a key risk factor for persistent thyroid carcinoma after initial management.
• Patients with lymph node metastasis require vigilant monitoring following thyroid cancer treatment.